Resultados de la búsqueda 1-10 of 4472 for hla genotype

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

3. Transplant Center de Mayo Clinic - Ensayos clínicos

   The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e., ...

4. Síndrome de Stevens-Johnson - Diagnóstico y tratamiento - Mayo Clinic

   HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: A systematic review. Clinical Pharmacology and Therapeutics. 2012;92:757. Wetter DA ...

5. Síndrome de Stevens-Johnson - Síntomas y causas - Mayo Clinic

   ... HLA-B*1502 antes de iniciar el tratamiento. Si tuviste ... HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: A systematic review.

6. Oncología (médica) - Ensayos clínicos

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

7. Clinical Genomics - Ensayos clínicos

   ... genotype, including understudied APOE2 and APOE4 homozygotes (HMs) at the lowest and highest risk and those APOE4 HMs and heterozygotes (HTs) who remain ...

8. Untitled

   Page 1.

9. Oncología (médica) - Ensayos clínicos

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

10. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...